Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 660

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes

Kahn, Steven E.·2001·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jcem.86.9.7713
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.86.9.7713

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Research works printed but not linked: 106

  1. Kahn, 1996, Pathophysiology of type II diabetes mellitus, In: Porte Jr D, Sherwin RS, eds. Diabetes mellitus. Stamford, CT: Appleton and Lange;, 487
  2. Best, 1982, The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes., Diabetes, 31, 333, 10.2337/diab.31.4.333 · DOI · Paper page
  3. Matthews, 1998, UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years, UK Prospective Diabetes Study (UKPDS) Group. Diabetes Med, 15, 297
  4. Levy, 1998, β-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study., Diabetes Med, 15, 290, 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M · doi:10.1002/(sici)1096-9136(199804)15:4<290::aid-dia570>3.0.co;2-m
  5. Brunzell, 1976, Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests., J Clin Endocrinol Metab, 42, 222, 10.1210/jcem-42-2-222 · DOI · Paper page
  6. Robertson, 1976, A role for α-adrenergic receptors in abnormal insulin secretion in diabetes mellitus., J Clin Invest, 57, 791, 10.1172/JCI108338 · DOI · Paper page
  7. Halter, 1979, Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation., J Clin Endocrinol Metab, 48, 946, 10.1210/jcem-48-6-946 · DOI
  8. Mako, 1977, Circulating proinsulin in patients with maturity-onset diabetes., Am J Med, 63, 865, 10.1016/0002-9343(77)90538-1 · DOI · Paper page
  9. Temple, 1990, Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics., Clin Endocrinol, 32, 689, 10.1111/j.1365-2265.1990.tb00915.x · DOI
  10. Kahn, 1995, Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese American men: impact of obesity., J Clin Endocrinol Metab, 80, 1399
  11. Enoki, 1992, Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus., Diabetes Res Clin Pract, 15, 97, 10.1016/0168-8227(92)90074-2 · DOI · Paper page
  12. Pupo, 1966, Carbohydrate metabolism in hyperadrenocorticism., Diabetes, 15, 24, 10.2337/diab.15.1.24 · DOI
  13. Grodsky, 1989, A new phase of insulin secretion: how will it contribute to our understanding of β-cell function?, Diabetes, 38, 673, 10.2337/diab.38.6.673 · DOI
  14. Daniel, 1999, Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion., Diabetes, 48, 1686, 10.2337/diabetes.48.9.1686 · DOI · Paper page
  15. Rhodes, 1987, Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway., J Cell Biol, 105, 145, 10.1083/jcb.105.1.145 · DOI · Paper page
  16. Sizonenko, 1993, Kinetics of proinsulin conversion in human islets., Diabetes, 42, 933, 10.2337/diab.42.6.933 · DOI
  17. Porte Jr, 1991, β-cells in type II diabetes mellitus., Diabetes, 40, 166, 10.2337/diab.40.2.166 · DOI · Paper page
  18. Metz, 1979, Paradoxical inhibition of insulin secretion by glucose in human diabetes mellitus., J Clin Endocrinol Metab, 48, 827, 10.1210/jcem-48-5-827 · DOI
  19. Polonsky, 1996, Non-insulin-dependent diabetes mellitus—a genetically programmed failure of the beta cell to compensate for insulin resistance., N Engl J Med, 334, 777, 10.1056/NEJM199603213341207 · DOI · Paper page
  20. Halter, 1978, Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin., J Clin Endocrinol Metab, 46, 952, 10.1210/jcem-46-6-952 · DOI
  21. Varsano-Aharon, 1970, Early insulin responses to glucose and to tolbutamide in maturity-onset diabetes., Metabolism, 19, 409, 10.1016/0026-0495(70)90092-2 · DOI
  22. Cerasi, 1975, Potentiation of insulin release by glucose in man. II. Role of the insulin response, and enhancement of stimuli other than glucose., Acta Endocrinol (Copenh), 79, 502, 10.1530/acta.0.0790502 · DOI
  23. Røder, 1998, Disproportionately elevated proinsulin levels reflect the degree of impaired B-cell secretory capacity in patients with non-insulin dependent diabetes mellitus., J Clin Endocrinol Metab, 83, 604
  24. Leahy, 1984, Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass., Diabetes, 33, 667, 10.2337/diab.33.7.667 · DOI
  25. Ward, 1988, Reduction of glycemic potentiation: a sensitive indicator of β-cell loss in partially pancreatectomized dogs., Diabetes, 37, 723, 10.2337/diab.37.6.723 · doi:10.2337/diab.37.6.723
  26. Matthews, 1983, Control of pulsatile insulin secretion in man., Diabetologia, 24, 231, 10.1007/BF00282705 · DOI · Paper page
  27. Bergstrom, 1989, Oscillatory insulin secretion in perifused isolated rat islets, Am J Physiol, 257, E479
  28. Matthews, 1983, Pulsatile insulin has greater hypoglycemic effect than continuous delivery., Diabetes, 32, 617, 10.2337/diab.32.7.617 · DOI · Paper page
  29. Ward, 1990, Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity., Diabetes, 39, 501, 10.2337/diab.39.4.501 · DOI
  30. Halban, 1991, Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic β cell., Diabetologia, 34, 767, 10.1007/BF00408349 · DOI
  31. Smeekens, 1990, Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2., J Biol Chem, 265, 2997, 10.1016/S0021-9258(19)39721-2 · DOI · Paper page
  32. Smeekens, 1991, Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans., Proc Natl Acad Sci USA, 88, 340, 10.1073/pnas.88.2.340 · DOI · Paper page
  33. Glauber, 1987, The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus., N Engl J Med, 316, 443, 10.1056/NEJM198702193160805 · DOI
  34. Porte Jr, 1989, Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet β-cell dysfunction?, Diabetes, 38, 1333, 10.2337/diab.38.11.1333 · DOI · Paper page
  35. Rhodes, 1994, What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism., Diabetes, 43, 511, 10.2337/diab.43.4.511 · DOI
  36. Westermark, 1987, Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islets., Proc Natl Acad Sci USA, 84, 3881, 10.1073/pnas.84.11.3881 · DOI · Paper page
  37. Kahn, 1990, Evidence of cosecretion of islet amyloid polypeptide and insulin byβ -cells., Diabetes, 39, 634, 10.2337/diab.39.5.634 · DOI · Paper page
  38. Leighton, 1988, Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro, Nature, 335, 632, 10.1038/335632a0 · DOI · Paper page
  39. Silvestre, 1990, Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas., Regul Pept, 31, 23, 10.1016/0167-0115(90)90192-Y · DOI
  40. Cooper, 1989, Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus., Biochim Biophys Acta, 1014, 247, 10.1016/0167-4889(89)90220-6 · DOI
  41. Young, 1995, Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin., Diabetologia, 38, 642, 10.1007/BF00401833 · DOI · Paper page
  42. Bagdade, 1974, Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity., J Lab Clin Med, 83, 563
  43. Kahn, 1996, Regulation of B-cell function in vivo: from health to disease., Diabetes Rev, 4, 372
  44. Ward, 1985, Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus., Diabetes, 34, 861, 10.2337/diab.34.9.861 · DOI · Paper page
  45. Ryan, 1995, Defects in insulin secretion and action in women with a history of gestational diabetes., Diabetes, 44, 506, 10.2337/diab.44.5.506 · DOI · Paper page
  46. Buchanan, 1999, Antepartum predictors of the development of type 2 diabetes in Latino women 11–26 months after pregnancies complicated by gestational diabetes., Diabetes, 48, 2430, 10.2337/diabetes.48.12.2430 · DOI · Paper page
  47. Dunaif, 1996, β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome., J Clin Endocrinol Metab, 81, 942
  48. Chen, 1985, Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function., J Clin Endocrinol Metab, 60, 13, 10.1210/jcem-60-1-13 · DOI · Paper page
  49. Kahn, 1990, Effect of exercise on insulin action, glucose tolerance and insulin secretion in aging, Am J Physiol, 258, E937
  50. Kahn, 1992, Exercise training delineates the importance of B-cell dysfunction to the glucose intolerance of human aging., J Clin Endocrinol Metab, 74, 1336
  51. Elbein, 1999, Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds., J Clin Endocrinol Metab, 84, 1398
  52. Chen, 1995, Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American men., Diabetes Care, 18, 747, 10.2337/diacare.18.6.747 · DOI
  53. Haffner, 1995, Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans., Diabetes, 44, 1386, 10.2337/diab.44.12.1386 · DOI · Paper page
  54. Larsson, 1995, Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans., Pancreas, 11, 201, 10.1097/00006676-199508000-00015 · DOI · Paper page
  55. Dechenes, 1998, Human aging is associated with parallel reductions in insulin and amylin release, Am J Physiol, 275, E785
  56. Landchild, 2000, Increased β-cell secretory demand is not the simple explanation for inefficient proinsulin processing and islet amyloid formation in type 2 diabetes., J Invest Med, 48, 21
  57. DeFronzo, 1992, Pathogenesis of NIDDM. A balanced overview., Diabetes Care, 15, 318, 10.2337/diacare.15.3.318 · DOI · Paper page
  58. Yki-Järvinen, 1992, Glucose toxicity., Endocr Rev, 13, 415
  59. Robertson, 1994, Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene., Diabetes, 43, 1085, 10.2337/diab.43.9.1085 · DOI · Paper page
  60. Unger, 1995, Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications., Diabetes, 44, 863, 10.2337/diab.44.8.863 · DOI · Paper page
  61. Johnson, 1989, Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus., N Engl J Med, 321, 513, 10.1056/NEJM198908243210806 · DOI · Paper page
  62. Kahn, 1992, Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus., J Clin Endocrinol Metab, 74, 192
  63. Bonner-Weir, 1983, Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release., J Clin Invest, 71, 1544, 10.1172/JCI110910 · DOI · Paper page
  64. Leahy, 1992, β-Cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion., Diabetes Care, 15, 442, 10.2337/diacare.15.3.442 · DOI · Paper page
  65. Sharma, 1995, The reduction of insulin gene transcription in HIT-T15 β cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression., Mol Endocrinol, 9, 1127
  66. Sharma, 1999, The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration., Diabetes, 48, 507, 10.2337/diabetes.48.3.507 · DOI · Paper page
  67. Kahn, 1992, Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans, Am J Physiol, 262, E518
  68. Byrne, 1995, Insulin secretion and clearance during low-dose graded glucose infusion, Am J Physiol, 268, E21
  69. Ward, 1984, Adaptation of B and A cell function during prolonged glucose infusion in human subjects, Am J Physiol, 246, E405
  70. Herman, 1988, Maladaptation of beta cell function to hyperglycemia in noninsulin-dependent diabetes mellitus, Diabetes, 37, 5A
  71. Martin, 1994, Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans., FEBS Lett, 356, 279, 10.1016/0014-5793(94)01284-9 · doi:10.1016/0014-5793(94)01284-9
  72. Skelly, 1996, Glucose-regulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin- producing MIN6 cell line., Diabetes, 45, 37, 10.2337/diab.45.1.37 · DOI
  73. Shimabukuro, 1997, Direct antidiabetic effect of leptin through triglyceride depletion of tissues., Proc Natl Acad Sci USA, 94, 4637, 10.1073/pnas.94.9.4637 · DOI · Paper page
  74. Cnop, 2000, Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age., Am J Pathol, 156, 237, 10.1016/S0002-9440(10)64724-4 · DOI
  75. Tsunehara, 1990, Diet of second-generation Japanese-American men with and without non-insulin-dependent diabetes., Am J Clin Nutr, 52, 731, 10.1093/ajcn/52.4.731 · DOI
  76. Chen, 1987, The role of dietary carbohydrate in the decreased glucose tolerance of the elderly., J Am Geriatr Soc, 35, 417, 10.1111/j.1532-5415.1987.tb04663.x · DOI
  77. Chen, 1988, Insulin resistance and β-cell dysfunction in aging: the importance of dietary carbohydrate., J Clin Endocrinol Metab, 67, 951, 10.1210/jcem-67-5-951 · DOI · Paper page
  78. Brunzell, 1971, Improved glucose tolerance with high carbohydrate feeding in mild diabetes., N Engl J Med, 284, 521, 10.1056/NEJM197103112841004 · DOI · Paper page
  79. Lee, 1995, Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice., Pancreas, 11, 206, 10.1097/00006676-199508000-00016 · DOI
  80. Kaiyala, 1999, Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding, Am J Physiol, 277, E659
  81. Mittelman, 2000, Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced β-cell response., Diabetes, 49, 2116, 10.2337/diabetes.49.12.2116 · DOI · Paper page
  82. Bjorntorp, 1996, The regulation of adipose tissue distribution in humans., Int J Obes Relat Metab Disord, 20, 291
  83. Sako, 1990, A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation., Endocrinology, 127, 1580, 10.1210/endo-127-4-1580 · DOI · Paper page
  84. Zhou, 1994, Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle., J Clin Invest, 93, 870, 10.1172/JCI117042 · DOI · Paper page
  85. Zhou, 1995, Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans., J Clin Endocrinol Metab, 80, 1584
  86. Briaud, 2001, Lipotoxicity of the pancreatic β-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids., Diabetes, 50, 315, 10.2337/diabetes.50.2.315 · DOI · Paper page
  87. Boden, 1995, Effects of a 48-h fat infusion on insulin secretion and glucose utilization., Diabetes, 44, 1239, 10.2337/diab.44.10.1239 · DOI · Paper page
  88. Poitout, 1998, Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans., Endocrinology, 139, 822, 10.1210/endo.139.3.5812 · DOI
  89. Zhang, 1995, TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic β-cell line (INS-1)., FEBS Lett, 377, 237, 10.1016/0014-5793(95)01272-9 · DOI
  90. Dunger, 1996, Tumor necrosis factor-α and interferon-γ inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement., Diabetes, 45, 183, 10.2337/diab.45.2.183 · DOI
  91. Saito, 1979, Differential volumetry of A, B, and D cells in the pancreatic islets of diabetic and nondiabetic subjects., Tohoku J Exp Med, 129, 273, 10.1620/tjem.129.273 · DOI
  92. Kloppel, 1985, Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited., Surv Synth Pathol Res, 4, 110
  93. Westermark, 1978, The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus., Diabetologia, 15, 417, 10.1007/BF01219652 · DOI · Paper page
  94. Efanova, 1998, Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration., J Biol Chem, 273, 33501, 10.1074/jbc.273.50.33501 · DOI · Paper page
  95. Verchere, 1996, Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide., Proc Natl Acad Sci USA, 93, 3492, 10.1073/pnas.93.8.3492 · DOI · Paper page
  96. Kahn, 2000, Oophorectomy promotes islet amyloid formation in a transgenic mouse model of type 2 diabetes., Diabetologia, 43, 1309, 10.1007/s001250051527 · DOI
  97. Andrikopoulos, 2000, β-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes., Diabetes, 49, 2056, 10.2337/diabetes.49.12.2056 · DOI
  98. Marshall, 1991, High-fat, low-carbohydrate diet and the etiology of non-insulin- dependent diabetes mellitus: the San Luis Valley Diabetes Study., Am J Epidemiol, 134, 590, 10.1093/oxfordjournals.aje.a116132 · DOI · Paper page
  99. Manson, 1992, A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus., Ann Epidemiol, 2, 665, 10.1016/1047-2797(92)90011-E · DOI · Paper page
  100. Lorenzo, 1994, Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus, Nature, 368, 756, 10.1038/368756a0 · DOI · Paper page
  101. Janson, 1999, The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles., Diabetes, 48, 491, 10.2337/diabetes.48.3.491 · DOI · Paper page
  102. Steppan, 2001, The hormone resistin links obesity to diabetes., Nature, 409, 307, 10.1038/35053000 · DOI · Paper page
  103. Souza, 1995, Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance., Diabetes, 44, 984, 10.2337/diab.44.8.984 · DOI
  104. Brown, 1999, A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat., Diabetes, 48, 1415, 10.2337/diabetes.48.7.1415 · DOI · Paper page
  105. Welch, 1990, Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects., J Clin Endocrinol Metab, 71, 1508, 10.1210/jcem-71-6-1508 · DOI · Paper page
  106. Vidal, 2001, Regulation of insulin secretion in vivo, In: Lowe Jr WL, eds. Genetics of diabetes mellitus. Stamford, CT: Kluwer;, 109

Cited by

See all 660

Metadata

Authors
Kahn, S. E.
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2001-09-01
Volume
86
Issue
9
Pages
4047-4058
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
DOI
10.1210/jcem.86.9.7713
OpenAlex
W2086547011
Cited by
660
References
56
FWCI
20.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes. https://app.cochat.ai/papers/10.1210/jcem.86.9.7713
The paper
Kahn, S. E. (2001). The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.86.9.7713

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.